New Trends in the Developments of Radiopharmaceuticals

摘要

Today, nuclear medicine has become an important diagnostic and therapeutic specialty in medical science. There has been a significant increase in the global demand for radiopharmaceuticals, with the increasing incidences of cardiac, neurological and cancer diseases, which tend to be widespread among the aging population. The global radiopharmaceutical applications market is expected to grow from $4.9 billion in 2010 and to $7.9 billion in 2015, at a CAGR of 9.25% from 2010 to 2015. Heightened interest in therapeutic efficiency, acceptance and utilization of hybrid imaging modalities, introduction of new diagnostic as well as therapeutic radiopharmaceuticals, will drive the global radiopharmaceutical market. Cardiovascular imaging, accounting for approximately 60% of the radiopharmaceuticals segment, represents the primary growth driver for the diagnostic radiopharmaceutical market, along with oncology imaging products. Reimbursement will continue to remain a key factor influencing growth in the radiopharmaceutical market.